))
Interview with Jeremy Steele - CEO of ASX Listed Control Bionics
Manage episode 494570860 series 3551735
Content provided by Chris Titley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chris Titley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
🎙️ Sub11: Control Bionics — EMG, Impact & Innovation
In this episode of Sub11, Chris Titley sits down with Jeremy Steele, CEO of ASX-listed medtech company Control Bionics.
Jeremy unpacks how a pioneering Australian technology—originally used by Stephen Hawking—is now changing lives across assistive communication, rehabilitation, and sports performance. From enabling non-verbal individuals to communicate, to boosting vertical jump height in elite athletes, Control Bionics is using surface electromyography (EMG) to interpret human intent like never before.
We discuss:
- How the NeuroNode and NeuroStrip work
- Partnerships and global expansion
- Their recent investment in NeuroBounce
- AI’s role in personalised performance and injury prevention
- Commercial traction, regulatory wins, and blue-sky potential
Plus, Jeremy shares a moving story of a young man in Japan who used the technology to speak to his mother for the first time in 20 years.
This is a 101 on a company using Australian-born tech to create global impact.
This content is factual information only, does not contain financial product advice and has not been prepared in consideration of your personal circumstances or needs. Views shared by individuals are their own personal views and not the views of Sub11. We are not licenced to provide financial product advice and cannot make investment recommendations to you. Investments carry risk. Please consider seeking professional financial advice, and read the relevant disclosure documents, before making any decisions to invest in financial products.
Control Bionics and Sub11 are in a commercial relationship which includes the production of media assets for use on LinkedIn. All questioning is created by Sub11, not Control Bionics.
15 episodes
Share
